By covering the full spectrum of topics relevant to peptidic drugs, this timely handbook serves as an introductory reference for both drug developers and biomedical researchers interested in pharmaceutically active peptides, presenting both the advantages and challenges associated with this molecula
Drug Safety Evaluation (Gad/Drug) || Front Matter
โ Scribed by Gad, Shayne Cox
- Book ID
- 119944184
- Publisher
- John Wiley & Sons, Inc.
- Year
- 2011
- Tongue
- English
- Weight
- 280 KB
- Edition
- 2
- Category
- Article
- ISBN
- 0470253169
No coin nor oath required. For personal study only.
โฆ Synopsis
drug Safety Evaluation
second Edition
shayne Cox Gad
the Updated And Expanded Safety Guide To All Aspects Of The Drug Development Process
drug Safety Evaluation, Second Edition Presents An All-inclusive, Practical Guide For Those Who Are Responsible For Ensuring The Safety Of Drugs And Biologics For Patients, For Health Care Providers, For Those Involved In The Manufacture Of Medicinal Products, And For All Those Who Need To Understand How The Safety Of These Products Is Evaluated.
this Second Edition Has Been Extensively Revised And Expanded To Respond To The Many Changes In Regulatory Requirements As Well As Pharmaceutical And Technological Developments. Drawing Upon More Than Twenty Years Of Experience, Author Shayne Gad Explains The Scientific And Philosophical Bases For Evaluating Specific Concerns (e.g., Cardiovascular Safety, Immunogenicity, Carcinogenicity, Development Toxicity, Etc.) To Provide Both Understanding And Guidance For Approaching New Problems.
individual Chapters Address Not Only The General Cases For Safety Evaluation Of Small And Large Molecules, But Also All The Significant Major Sub-cases: Imaging Agents, Dermal And Inhalation Route Drugs, Vaccines, And Gene-therapy Products. Among The Wide Variety Of Topics Covered Are:
-
acute Toxicity Testing In Pharmaceutical Safety Evaluation
-
genotoxicity
-
safety Assessment Of Inhalant Drugs
-
immunotoxicology In Pharmaceutical Development
-
large Animal Studies
-
evaluation Of Human Tolerance And Safety In Clinical Trials
more Pertinent And Practical Than Ever To The Industry, Drug Safety Evaluation, Second Edition Provides A Road Map For Safety Assessment As An Integral Part Of The Development Of New Drugs And Therapeutics.
booknews
gad Brings Some 25 Years Of Experience In Toxicology, Drug Development, And Risk Assessment To This Practical Guide For Those In The Pharmaceutical And Biotechnology Industries Responsible For Ensuring The Safety Of Drugs And Biologics To Patients, Health Care Providers, Manufacturers Of Medicinal Products, And Those Concerned With Safety Evaluation. The Text Addresses Safety Assessment As An Integral Part Of The Development Of New Drugs And Therapeutics, Specific Approaches To Evaluating Hazards, Problems That Are Encountered And Their Solutions, And Scientific And Philosophical Bases For The Evaluation Of Specific Concerns To Provide An Understanding And Guidance For Approaching New Problems. A Sampling Of Topics: Acute Toxicity Testing, Genotoxicity, Carcinogenicity Studies, Safety Assessment Of Inhalant Drugs, Occupational Toxicology In The Pharmaceutical Industry, Large Animal Studies, Evaluation Of Human Tolerance And Safety In Clinical Trials. Annotation C. Book News, Inc., Portland, Or (booknews.com)
๐ SIMILAR VOLUMES
The Vast Majority Of Drugs Are Organic Molecular Entities. A Clear Understanding Of The Organic Chemistry Of Drug Degradation Is Essential To Maintaining The Stability, Efficacy, And Safety Of A Drug Product Throughout Its Shelf-life. During Analytical Method Development, Stability Testing, And Phar